EMA Concludes AstraZeneca COVID-19 Vaccine ‘Safe and Effective’
Europe's drug regulator, the Europe Medicines Agency (EMA), said Thursday the AstraZeneca COVID-19 vaccine is safe and effective in protecting people from the disease and its benefits outweigh its possible risks. Speaking to a remote news conference from the agency's Amsterdam headquarters, Executive Director Emer Cooke said the review by the agency's safety committee also concluded that the vaccine is not associated with an increase in the overall risk of blood clots, also known as thromboembolic events. Several European nations in the past week had suspended administering the AstraZeneca vaccine after reports patients who had received it had developed blood clots, that, in a few cases, led to death. The EMA review sprang from those reports. People arrive at a vaccination center to receive a dose of Oxford/AstraZeneca's COVID-19 vaccine in Antwerp,…